Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients
Breast cancer is the leading cause of female cancer-related death; however, novel biomarkers for predicting cancer recurrence still need to be explored. Aberrant expression of S100A8 has been reported to be related to tumor progression in various cancer types. This study aims to evaluate the clinica...
Main Authors: | Dujuan Wang, Guohong Liu, Balu Wu, Li Chen, Lihua Zeng, Yunbao Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00496/full |
Similar Items
-
S100β as a serum marker in endocrine resistant breast cancer
by: Sara Charmsaz, et al.
Published: (2017-04-01) -
Axillary Lymph Nodal Metastasis from Carcinoma of Unknown Primary (Cupax)- An Orphan Disease
by: Renuka Bangalore Nagaraj, et al.
Published: (2021-08-01) -
Estrogen and progesterone receptor testing in breast carcinoma: concordance of results between local and reference laboratories in Brazil
by: Sheila Cristina Lordelo Wludarski, et al. -
S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1
by: Xiaojun Zhang, et al.
Published: (2023-12-01) -
Survey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer
by: Atena Azami, et al.
Published: (2020-01-01)